Health & Biotech
Health & Biotech
‘Tide is turning for the healthcare sector’ – ASX biotechs making strong gains in 2024 Part 2
Health & Biotech
Neurotech extends clinical trials for the $US2bn Rett Syndrome market
Health & Biotech
Weed Week: Cannabis can ‘kill melanoma’; and Germany legalises weed possession
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps Lunch Wrap: Markets higher yada yada… Germans legalise Pot!
News
Closing Bell: Thursday and the ASX200 is flat and porous. I am unhappy… But at least Bega made a lot of cheese
Health & Biotech
Weed Week: Iron Mike throws down challenge to Biden, and recent ASX pot winners
Health & Biotech
Fundie Merchant Group picks four biotech stocks that could rip as sector hits rude health again
Health & Biotech
Melodiol subsidiary Mernova expands products in six lucrative Canadian provinces
News
ASX Small Caps and IPO Weekly Wrap: ASX 200 oozes to a fraught +0.75pc weekly ‘win’
Health & Biotech
Weed Week: Hey stoners, exercise is even better on weed; and recent ASX pot winners
Health & Biotech
Melodiol subsidiaries deliver $2 million revenue to group in strong start to year
Health & Biotech
ASX Health Stocks: Truscreen to start cervical cancer screening women in Mexico after approval
Health & Biotech
‘Monumental’– Bioxyne subsidiary awarded Australia’s first GMP licence to manufacture psilocybin and MDMA
Health & Biotech
Why the buzz for kava is growing, and how The Calmer Co. is capitalising
News
Rise and Shine: Everything you need to know before the ASX opens
News